SPARC gene variants predict survival of locally advanced and metastatic pancreatic cancer patients treated with chemotherapy

被引：0
|
作者：
Arqueros, C. [1 ]
Paez, D. [1 ]
Salazar, J. [2 ]
Del Rio, E. [2 ]
Arranz, M. J. [2 ]
Mora, J. [3 ]
Sullivan, I. [1 ]
Tobena, M. [1 ]
Martin Richard, M. [1 ]
Sebio, A. [1 ]
Baiget, M. [2 ]
机构：
[1] Hosp St Pau Barcelona, Med Oncol, Barcelona, Spain
[2] Hosp St Pau Barcelona, Genet, Barcelona, Spain
[3] Hosp St Pau Barcelona, Pathol Anat, Barcelona, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30093-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
205
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [31] Chemotherapy in locally advanced and metastatic bladder cancer
    Kuczyk, MA
    Zimmermann, R
    Merseburger, A
    Anastasiadis, A
    Corvin, S
    Hartmann, JT
    Stenzl, A
    EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (03) : 79 - 88
  • [32] Favourable outcomes in locally advanced and metastatic pancreatic cancer treated with modified FOLFIRINOX as second-line chemotherapy.
    Talbot, Alice
    Dean, Andrew Peter
    McClean, Aine
    Colfer, Michelle
    Newell, Cormac
    Theze, Sarah
    Das, Adarsh
    McCartney, Conor
    Walsh, Eoin
    Crowley, Niamh
    Tutty-Bardon, Cliodhna
    Shaughnessy, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16252 - E16252
  • [33] Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease free survival in patients with locally advanced breast cancer - Closing
    Kuerer, HM
    AMERICAN JOURNAL OF SURGERY, 1998, 176 (06): : 508 - 509
  • [34] Blood Neutrophil–Lymphocyte Ratio Predicts Survival in Patients with Advanced Pancreatic Cancer Treated with Chemotherapy
    Guopei Luo
    Meng Guo
    Zuqiang Liu
    Zhiwen Xiao
    Kaizhou Jin
    Jiang Long
    Liang Liu
    Chen Liu
    Jin Xu
    Quanxing Ni
    Xianjun Yu
    Annals of Surgical Oncology, 2015, 22 : 670 - 676
  • [35] Stereotactic radiotherapy after chemotherapy in patients with locally advanced pancreatic cancer
    LE ROY, C.
    Barbe, R.
    Sun, R.
    Burtin, P.
    Gelli, M.
    Deutsch, E.
    Durand-Labrunie, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1089 - S1089
  • [36] LOCALLY ADVANCED AND METASTATIC PANCREATIC CANCER: AN ASSESSMENT OF THE PROVISION OF CHEMOTHERAPY AT A TERTIARY REFERRAL HOSPITAL
    Christie, Hayden
    Burge, Matthew
    Eastgate, Melissa
    Wyld, David
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 174 - 174
  • [37] Intra-arterial chemotherapy in patients with locally advanced pancreatic cancer
    Jamitzky, T
    Lange, OF
    Scheef, W
    Emde, H
    Beckers, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 889 - 889
  • [38] Maintenance chemotherapy after chemoradiation in patients with locally advanced pancreatic cancer
    Mizrahi, Jonathan D.
    Moningi, Shalini
    Nogueras-Gonzalez, Graciela M.
    Wolff, Robert A.
    Javle, Milind M.
    Varadhachary, Gauri R.
    Ho, Linus
    Fogelman, David R.
    Raghav, Kanwal P.
    Overman, Michael J.
    Crane, Christopher H.
    Herman, Joseph M.
    Koong, Albert C.
    Koay, Eugene J.
    Rogers, Jane E.
    Pant, Shubham
    CANCER RESEARCH, 2019, 79 (24)
  • [39] Relevance of combination chemotherapy in locally advanced or metastatic pancreatic carcinoma
    Hanauske, AR
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (11) : 660 - 661
  • [40] Prognostic Factors for Survival and Resection in Patients With Initial Nonresectable Locally Advanced Pancreatic Cancer Treated With Chemoradiotherapy
    Bjerregaard, Jon K.
    Mortensen, Michael B.
    Jensen, Helle A.
    Nielsen, Morten
    Pfeiffer, Per
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (03): : 909 - 915
12345